Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Essential Medicines at the National Level: The Global Asthma Network's Essential Asthma Medicines Survey 2014

Title: Essential Medicines at the National Level: The Global Asthma Network's Essential Asthma Medicines Survey 2014
Authors: Bissell, K; Ellwood, P; Ellwood, E; Chiang, C-Y; Marks, GB; El Sony, A; Asher, I; Billo, N; Perrin, C; Billo, NE; Garcia-Marcos, L; Mallol, J; Pearce, N; Strachan, D; Priftanji, A; Boukari, R; Taright, S; Gomez, M; Baghdasaryan, A; Burgess, S; Mattes, J; Tai, A; Riedler, J; Shpakou, A; Weyler, J; Lawin, H; de Abruzzese, AJ; Domuz, S; Brandao, HV; Camargos, PAM; Fischer, GB; Menezes, AM; Porto Neto, AC; Rosario, N; Sole, D; Mustakov, TB; Birba, E; Ngahane, MBH; Tse, SM; Standring, P; Aguirre, V; Calvo Gil, MA; Chen, Y-Z; Kan, X; Garcia, E; Niederbacher, J; Obel, KB; Soto-Quiros, ME; Banac, S; Yiallouros, P; Lochte, L; Barba, S; Bustos, C; El Falaki, M; Figueroa Colorado, M; Weihe, P; Lal, VA; Makela, M; Annesi-Maesano, I; Raherison, C; Gotua, M; von Mutius, E; Addo-Yobo, EO; Akpinar-Elci, M; Lai, CKW; Novak, Z; Kabra, SK; Ilangho, RP; Pherwani, AV; Sharma, SK; Sukumaran, TU; Dalimunthe, W; Karimi, M; Masjedi, M-R; Manning, P; Shohat, T; Forastiere, F; La Grutta, S; Petronio, MG; Piffer, S; Kahwa, E; Odajima, H; Abu-Ekteish, F; Amukoye, EI; Esamai, FO; Hong, S-J; Neziri-Ahmetaj, L; Momen, JA; Akkhavong, K; Svabe, V; Vlaski, E; Mortimer, K; Daud, M; Montefort, S; Del Rio Navarro, BE; Jimenez Gonzalez, CA; Merida-Palacio, JV; Paramo-Arroyo, RF; Munkhbayarlakh, S; Brunekreef, B; Currie, S; Douwes, J; Graham, D; Hancox, R; Moyes, C; Pattemore, P; Vis, K; Cordero, RMZ; Ayuk, A; Falade, AG; Garba, IB; Hammangabdo, A; Onyia, N; Pulu, M; Nystad, W; Al-Rawas, O; Yusuf, MO; Watson, BM; El Sharif, N; Cukier, G; Chiarella, P; Pagcatipunan, R; Breborowicz, A; Lis, G; Morais-Almeida, M; Deleanu, D; Kamaltynova, E; Kondiurina, EG; Esera-Tulifau, L; Al-Ghamdi; Memish, ZA; Nahhas, MA; Yousef, A; Toure, NO; Visnjevac, D; Zivkovic, Z; Deen, GF; Goh, DYT; Masekala, R; Zar, HJ; Carvajal-Uruena, I; Gonzalez Diaz, C; Korta Murua, J; Luna-Paredes, C; Morales-Suarez-Varela, M; Praena-Crespo, M; Kudagammana, ST; Mohammad, Y; Guo, YL; Huang, J-L; Lao-Araya, M; Teeratakulpisarn, J; Vichyanond, P; Anderson, S; Tidjani, O; Iosefa, T; Aho, G; Dookeeram, D; Hamzaoui, A; Yorgancioglu, A; Ituaso-Conway, N; Worodria, W; Fedortsiv, O; Mahboub, B; Mansur, AH; Kumar, H; Valentin-Rostan, M; Harrison, G; Fiocchi, A; Le, LTT; Wa Somwe, S; Manangazira, P; Grp, GANS
Publisher Information: MDPI
Publication Year: 2019
Collection: St George's University of London: Repository
Description: Patients with asthma need uninterrupted supplies of affordable, quality-assured essential medicines. However, access in many low- and middle-income countries (LMICs) is limited. The World Health Organization (WHO) Non-Communicable Disease (NCD) Global Action Plan 2013–2020 sets an 80% target for essential NCD medicines’ availability. Poor access is partly due to medicines not being included on the national Essential Medicines Lists (EML) and/or National Reimbursement Lists (NRL) which guide the provision of free/subsidised medicines. We aimed to determine how many countries have essential asthma medicines on their EML and NRL, which essential asthma medicines, and whether surveys might monitor progress. A cross-sectional survey in 2013–2015 of Global Asthma Network principal investigators generated 111/120 (93%) responses—41 high-income countries and territories (HICs); 70 LMICs. Patients in HICs with NRL are best served (91% HICs included ICS (inhaled corticosteroids) and salbutamol). Patients in the 24 (34%) LMICs with no NRL and the 14 (30%) LMICs with an NRL, however no ICS are likely to have very poor access to affordable, quality-assured ICS. Many LMICs do not have essential asthma medicines on their EML or NRL. Technical guidance and advocacy for policy change is required. Improving access to these medicines will improve the health system’s capacity to address NCDs.
Document Type: article in journal/newspaper
File Description: application/pdf
Language: English
ISSN: 1660-4601
Relation: https://openaccess.sgul.ac.uk/id/eprint/110790/1/ijerph-16-00605-v2.pdf; Bissell, K; Ellwood, P; Ellwood, E; Chiang, C-Y; Marks, GB; El Sony, A; Asher, I; Billo, N; Perrin, C; Asher, I; et al. Bissell, K; Ellwood, P; Ellwood, E; Chiang, C-Y; Marks, GB; El Sony, A; Asher, I; Billo, N; Perrin, C; Asher, I; Billo, NE; Bissell, K; Chiang, C-Y; El Sony, A; Ellwood, P; Garcia-Marcos, L; Mallol, J; Marks, GB; Pearce, N; Strachan, D; Priftanji, A; Boukari, R; Taright, S; Gomez, M; Baghdasaryan, A; Burgess, S; Marks, GB; Mattes, J; Tai, A; Riedler, J; Shpakou, A; Weyler, J; Lawin, H; de Abruzzese, AJ; Domuz, S; Brandao, HV; Camargos, PAM; Fischer, GB; Menezes, AM; Porto Neto, AC; Rosario, N; Sole, D; Mustakov, TB; Birba, E; Ngahane, MBH; Tse, SM; Standring, P; Aguirre, V; Calvo Gil, MA; Chen, Y-Z; Kan, X; Garcia, E; Niederbacher, J; Obel, KB; Soto-Quiros, ME; Banac, S; Yiallouros, P; Lochte, L; Barba, S; Bustos, C; El Falaki, M; Figueroa Colorado, M; Weihe, P; Lal, VA; Makela, M; Annesi-Maesano, I; Raherison, C; Annesi-Maesano, I; Gotua, M; von Mutius, E; Addo-Yobo, EO; Akpinar-Elci, M; Lai, CKW; Novak, Z; Kabra, SK; Ilangho, RP; Pherwani, AV; Sharma, SK; Sukumaran, TU; Dalimunthe, W; Karimi, M; Masjedi, M-R; Manning, P; Shohat, T; Forastiere, F; La Grutta, S; Petronio, MG; Piffer, S; Kahwa, E; Odajima, H; Abu-Ekteish, F; Amukoye, EI; Esamai, FO; Hong, S-J; Neziri-Ahmetaj, L; Momen, JA; Akkhavong, K; Svabe, V; Vlaski, E; Mortimer, K; Daud, M; Montefort, S; Del Rio Navarro, BE; Jimenez Gonzalez, CA; Merida-Palacio, JV; Paramo-Arroyo, RF; Munkhbayarlakh, S; Brunekreef, B; Annesi-Maesano, I; Asher, I; Currie, S; Douwes, J; Graham, D; Hancox, R; Moyes, C; Pattemore, P; Vis, K; Cordero, RMZ; Ayuk, A; Falade, AG; Garba, IB; Hammangabdo, A; Onyia, N; Pulu, M; Nystad, W; Al-Rawas, O; Yusuf, MO; Watson, BM; El Sharif, N; Cukier, G; Chiarella, P; Pagcatipunan, R; Breborowicz, A; Lis, G; Morais-Almeida, M; Annesi-Maesano, I; Deleanu, D; Kamaltynova, E; Kondiurina, EG; Esera-Tulifau, L; Al-Ghamdi; Memish, ZA; Nahhas, MA; Yousef, A; Toure, NO; Visnjevac, D; Zivkovic, Z; Deen, GF; Goh, DYT; Masekala, R; Zar, HJ; Carvajal-Uruena, I; Garcia-Marcos, L; Gonzalez Diaz, C; Korta Murua, J; Luna-Paredes, C; Morales-Suarez-Varela, M; Praena-Crespo, M; Kudagammana, ST; El Sony, A; Mohammad, Y; Guo, YL; Huang, J-L; Lao-Araya, M; Teeratakulpisarn, J; Vichyanond, P; Anderson, S; Tidjani, O; Iosefa, T; Aho, G; Dookeeram, D; Hamzaoui, A; Yorgancioglu, A; Ituaso-Conway, N; Worodria, W; Fedortsiv, O; Mahboub, B; Mansur, AH; Kumar, H; Valentin-Rostan, M; Harrison, G; Fiocchi, A; Le, LTT; Wa Somwe, S; Manangazira, P; Grp, GANS (2019) Essential Medicines at the National Level: The Global Asthma Network's Essential Asthma Medicines Survey 2014. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 16 (4). p. 605. ISSN 1660-4601 https://doi.org/10.3390/ijerph16040605 SGUL Authors: Strachan, David Peter
Availability: https://openaccess.sgul.ac.uk/id/eprint/110790/
Rights: cc_by_4
Accession Number: edsbas.9A984AF
Database: BASE